Adaptimmune Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ADAP and other ETFs, options, and stocks.

About ADAP

Adaptimmune Therapeutics Plc is commercial-stage cell therapy company, which focuses on providing novel cell therapies to people with cancer. Its clinical pipeline includes Afami-cel, Lete-cel, and ADP-A2M4CD8.

CEO

Adrian Rawcliffe

CEOAdrian Rawcliffe

Employees

449

Employees449

Headquarters

Abingdon, Oxfordshire

HeadquartersAbingdon, Oxfordshire

Founded

2008

Founded2008

Employees

449

Employees449

ADAP Key Statistics

Market cap

150.33M

Market cap150.33M

Price-Earnings ratio

-2.73

Price-Earnings ratio-2.73

Dividend yield

—

Dividend yield—

Average volume

2.63M

Average volume2.63M

High today

$0.63

High today$0.63

Low today

$0.58

Low today$0.58

Open price

$0.59

Open price$0.59

Volume

5.19M

Volume5.19M

52 Week high

$2.05

52 Week high$2.05

52 Week low

$0.42

52 Week low$0.42

Analyst ratings

67%

of 9 ratings

Buy

66.7%

Hold

22.2%

Sell

11.1%